EQS-Adhoc
LifeWatch AG: BioTelemetry publishes the definitive notice of the interim result
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Offer BioTelemetry publishes the definitive notice of the interim result |
ZUG, Switzerland, June 14, 2017 - With the definitive interim result now available, BioTelemetry (the Offeror) confirmed today that the shareholders tendered approximately 83 percent of the outstanding total shares of Lifewatch AG during the tender period and declared the offer to be successful, subject to the satisfaction of certain offer conditions.
Including the LifeWatch shares tendered into the offer, the participation of the Offeror and the persons acting in concert with the Offeror at the end of the offer period on June 8, 2017, 4.00 p.m. CET, is 15,425,499 LifeWatch shares in total. This corresponds to 83 percent of the voting rights and the share capital of LifeWatch.
The additional acceptance period of 10 trading days for the subsequent acceptance of the offer will start on June 15, 2017, and is expected to run until June 28, 2017, 4.00 p.m. CET. Subject to the satisfaction of all conditions in accordance with the offer prospectus, settlement of the offer is expected to take place on July 13, 2017.
For further questions:
LifeWatch AG, Andrew Moore, CFO
c/o Communicators AG , Ralph Spillmann
Mobile: +41 79 514 64 84
E-Mail: investor-relations@lifewatch.com
About LifeWatch AG
LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE), Switzerland, is a leading healthcare technology and solution company, specializing in advanced digital health systems and
wireless remote diagnostic patient monitoring services. LifeWatch's services provide physicians with critical information to determine appropriate treatment and thereby improve patient outcomes.
LifeWatch AG has operative subsidiaries in the United States, in Switzerland, Israel and Turkey, and is the parent company of LifeWatch Services Inc., LifeWatch Technologies, Ltd. and LifeWatch
Turkey Holding AG (joint venture). LifeWatch Services, Inc. is a leading U.S.-based provider of cardiac monitoring services. LifeWatch Technologies Ltd., based in Israel, is a leading manufacturer
of digital health products. LifeWatch Sağlık Hizmetlerine A.S. is the operative Turkish subsidiary of LifeWatch Turkey Holding AG and provider of mobile cardiac telemetry services in Turkey. For
additional information, please visit www.lifewatch.com.